John Richard Heys

Title: The Innovations of John Richard Heys

Introduction

John Richard Heys is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. His work has the potential to impact the treatment of various diseases and conditions.

Latest Patents

John Richard Heys holds a patent for a radioactive compound known as Ligands. This compound has the formula and pharmaceutically-acceptable salts, wherein R and Ar are defined in the specification. The patent also covers enantiomers, in vivo-hydrolysable precursors, pharmaceutical compositions, and formulations containing them. Furthermore, it includes methods of using these compounds to treat diseases, either alone or in combination with other therapeutically-active substances. The patent outlines processes and intermediates used to prepare these compounds and their uses for diagnostic and analytic purposes.

Career Highlights

John Richard Heys is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative solutions in the pharmaceutical industry. He has been instrumental in advancing research and development efforts within the company.

Collaborations

Some of his notable coworkers include Mark A. Smith and Peter Dorff. Their collaboration has contributed to the success of various projects and innovations within the company.

Conclusion

John Richard Heys is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in treatment methodologies. His patent for Ligands exemplifies his commitment to innovation and the betterment of healthcare.